Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent trends in mortality from benign prostatic hyperplasia.

Fabio Levi1, Franca Lucchini, Eva Negri

  • 1Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchâtel, Institut universitaire de médecine sociale et préventive, CHUV-Falaises 1, 1011 Lausanne, Switzerland. Fabio.Levi@inst.hospvd.ch

The Prostate
|May 29, 2003
PubMed
Summary

Mortality from benign prostatic hyperplasia (BPH) has significantly decreased in developed nations over recent decades. However, higher BPH rates in Eastern Europe suggest potential for further improvements in care and outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urological cancer: Aspirin and the risk of prostate cancer mortality.

Nature reviews. Clinical oncology·2012
Same author

Statins and primary liver cancer: a meta-analysis of observational studies.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2012
Same author

Lung cancer mortality in European women: trends and predictions.

Lung cancer (Amsterdam, Netherlands)·2012
Same author

Tobacco control: economic aspects of smoking.

Preventive medicine·2012
Same author

Time to first cigarette and upper aerodigestive tract cancer risk in Japan.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2012
Same author

Re: coffee consumption and prostate cancer risk and progression in the health professional follow-up study.

Journal of the National Cancer Institute·2012

Area of Science:

  • Urology
  • Public Health
  • Epidemiology

Background:

  • Examined mortality trends for benign prostatic hyperplasia (BPH) over several decades.
  • Included comparative data from Europe, the USA, and Japan.

Purpose of the Study:

  • To analyze historical trends in BPH-related mortality.
  • To compare mortality rates across different developed regions.

Main Methods:

  • Utilized World Health Organisation database for cancer death certification data.
  • Focused on data related to benign prostatic hyperplasia (BPH).

Main Results:

  • Overall BPH mortality in the European Union (EU) declined by over 96% from the early 1950s to the late 1990s.
  • The USA and Japan showed comparable declines, with lower rates than the EU by the late 1990s.

Related Experiment Videos

  • Eastern Europe exhibited downward BPH mortality trends but maintained rates approximately fourfold higher than the EU.

    • Conclusions:

    • Benign prostatic hyperplasia (BPH) mortality rates have consistently decreased in developed countries.
    • Excess BPH mortality in Eastern Europe highlights opportunities for further mortality reduction.